CNS-Active Polypharmacy Examined in Seniors With Dementia
Most common medication was gabapentin, which was linked to 33.0 percent of polypharmacy-days
COVID-19 Vaccine Hesitancy, Mistrust High Among Black Americans
High hesitancy even seen among Black health care workers, survey finds
Most Women Would Vaccinate Their Children Against COVID-19
And, more than half of pregnant women would also accept a COVID-19 vaccine for themselves
AAN: Fetal Exposure to Antiseizure Meds Has No Neuropsychological Impact
No difference found in primary outcome of Verbal Index score at age 3 years with fetal exposure to ASM or for those born to healthy women
No Effect of Low-Dose Atorvastatin Found for Muscle Symptoms
For participants reporting muscle symptoms when taking statins, no overall effect seen for atorvastatin 20 mg versus placebo
Medicare Payments for Brand-Name Neurology Meds Soaring
From 2013 to 2017, number of claims increased 7.6 percent, but total payments increased 50.4 percent
States, Pharmacies to Receive Additional Doses of COVID-19 Vaccines
The United States is now delivering an average of 2.17 million doses of COVID-19 vaccines a day
Airlines Ask White House for Standardized COVID-19 Credentials for Passengers
Airline industry believes that one set of rules for such documents will help revive travel
White House Provides $250 Million to Reduce COVID-19 Inequities
Initiative is meant to help local governments boost COVID-19 testing, contact tracing, and other pandemic mitigation measures
Nonprescription At-Home COVID-19 Test Receives Emergency Approval
The FDA also issued emergency use authorization for prescription at-home test kit for those suspected of COVID-19 within six days of symptom onset
